{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:49:02Z","timestamp":1791564542311,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.medj.2026.101267","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:18:01Z","timestamp":1790695081000},"page":"101267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 receptor agonist exposure in the periconceptional period and adverse obstetric outcomes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"given":"Francesco","family":"D'Antonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Flacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamberto","family":"Manzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Samara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-7670","authenticated-orcid":false,"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101267_bib1","unstructured":"World Health Organization. (2025) Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"10.1016\/j.medj.2026.101267_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s13679-021-00453-x","article-title":"Sex\/gender differences in obesity prevalence, comorbidities, and treatment","volume":"10","author":"Cooper","year":"2021","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.medj.2026.101267_bib3","series-title":"IDF Diabetes Atlas","year":"2025"},{"key":"10.1016\/j.medj.2026.101267_bib4","unstructured":"International Diabetes Federation. . Gestational Diabetes. International Diabetes Federation; Accessed https:\/\/idf.org\/about-diabetes\/types-of-diabetes\/gestational-diabetes\/"},{"key":"10.1016\/j.medj.2026.101267_bib5","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000004395","article-title":"Obesity in pregnancy: ACOG Practice Bulletin, Number 230","volume":"137","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.medj.2026.101267_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/uog.27712","article-title":"Evidence-based interventions to address persistent maternal mortality rates","volume":"64","author":"Samara","year":"2024","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.medj.2026.101267_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.103191","article-title":"Outcomes of maternal periconceptional exposure to glucagon-like peptide-1 receptor agonists: a scoping review of evidence and reporting trends","volume":"48","author":"Lee","year":"2026","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.medj.2026.101267_bib8","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1097\/MS9.0000000000004189","article-title":"GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review","volume":"87","author":"Saad Alfaiz","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.medj.2026.101267_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2026.101267_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2026.101267_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5694\/mja2.70026","article-title":"Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011\u20132022: a retrospective open cohort study","volume":"223","author":"Thapaliya","year":"2025","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.medj.2026.101267_bib12","series-title":"The Developing Human: Clinically Oriented Embryology","author":"Moore","year":"2020"},{"key":"10.1016\/j.medj.2026.101267_bib13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.113.S3.957","article-title":"Environmental causes of human congenital malformations: the pediatrician\u2019s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors","volume":"113","author":"Brent","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.medj.2026.101267_bib14","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/clinem\/dgaf288","article-title":"Preexisting diabetes and pregnancy: an Endocrine Society and European Society of Endocrinology joint clinical practice guideline","volume":"110","author":"Wyckoff","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.medj.2026.101267_bib15","unstructured":"U.S. Food and Drug Administration (2025). Victoza (Liraglutide) Injection, for Subcutaneous Use: Prescribing Information."},{"key":"10.1016\/j.medj.2026.101267_bib16","unstructured":"U.S. Food and Drug Administration (2025). Ozempic (Semaglutide) Injection, for Subcutaneous Use: Prescribing Information."},{"key":"10.1016\/j.medj.2026.101267_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.medj.2026.101267_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoag015","article-title":"Periconceptional GLP-1 receptor agonist exposure and obstetric outcomes: a Danish nationwide cohort study","volume":"2026","author":"Hviid","year":"2026","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.medj.2026.101267_bib19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/dom.70334","article-title":"Unintentional periconceptional exposure to glucagon-like peptide-1 receptor agonists and adverse pregnancy outcomes: a nationwide cohort study in Taiwan","volume":"28","author":"Chou","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.medj.2026.101267_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjcard.2025.03.013","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes","volume":"246","author":"Hanif","year":"2025","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.medj.2026.101267_bib21","doi-asserted-by":"crossref","first-page":"116.e1","DOI":"10.1016\/j.ajog.2025.01.019","article-title":"Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes","volume":"233","author":"Imbroane","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.medj.2026.101267_bib22","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1001\/jama.2025.20951","article-title":"Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation","volume":"334","author":"Maya","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2026.101267_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/AOG.0000000000005995","article-title":"Gestational weight gain and hypertensive disorders of pregnancy with prepregnancy and early pregnancy glucagon-like peptide-1 receptor agonist exposure","volume":"147","author":"Pondugula","year":"2026","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.medj.2026.101267_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.medj.2026.101267_bib25","article-title":"No rise in pregnancy rates in the year following GLP-1 prescription","author":"Bartelt","year":"2024","journal-title":"Epic Research"},{"key":"10.1016\/j.medj.2026.101267_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70211","article-title":"Prescription drugs in pregnancy and congenital malformations: a population-based safety screening study","volume":"34","author":"Broe","year":"2025","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.medj.2026.101267_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.EDE.0000059921.71494.D1","article-title":"Maternal body mass index and the risk of preeclampsia: a systematic overview","volume":"14","author":"O\u2019Brien","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.medj.2026.101267_bib28","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin","volume":"135","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.medj.2026.101267_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.medj.2026.101267_bib30","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.2337\/dc26-S015","article-title":"15. Management of diabetes in pregnancy: Standards of Care in Diabetes\u20142026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2026.101267_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.102649","article-title":"GLP-1 receptor agonist exposure during pregnancy: a systematic review and meta-analysis of adverse pregnancy outcomes","volume":"5","author":"Kodali","year":"2026","journal-title":"JACC. Adv."},{"key":"10.1016\/j.medj.2026.101267_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2025.103046","article-title":"Evaluation of GLP-1 receptor agonists in obstetrics and perinatal outcomes: a systematic review and meta-analysis","volume":"54","author":"Armstrong","year":"2025","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.medj.2026.101267_bib33","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1111\/dom.70699","article-title":"Safety of GLP-1 and dual GLP-1\/GIP receptor agonists in preconception, pregnancy, and lactation: a systematic review of maternal, fetal, and neonatal outcomes","volume":"28","author":"Ozbek","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.medj.2026.101267_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40272-026-00746-5","article-title":"GLP-1 receptor agonist use across preconception, pregnancy, and the postpartum periods","volume":"28","author":"Porterfield","year":"2026","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.medj.2026.101267_bib39","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1111\/dom.16437","article-title":"Glucagon-like peptide 1 receptor agonists\u2019 use during pregnancy: safety data from regulatory clinical trials","volume":"27","author":"Parker","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.medj.2026.101267_bib34","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41401-025-01501-1","article-title":"Semaglutide ameliorates metabolic disorders in offspring via regulation of oocyte ROS in mice with pre-pregnancy obesity","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.medj.2026.101267_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/ijms27020759","article-title":"A systematic review on GLP-1 receptor agonists in reproductive health: integrating IVF data, ovarian physiology, and molecular mechanisms","volume":"27","author":"Voros","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2026.101267_bib35","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.medj.2026.101267_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.medj.2026.101267_bib37","series-title":"Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0","author":"Deeks","year":"2011"},{"key":"10.1016\/j.medj.2026.101267_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10654-015-0104-8","article-title":"Generic versus brand-name drugs used in cardiovascular diseases","volume":"31","author":"Manzoli","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.medj.2026.101267_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.medj.2026.101267_bib43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe or lethal COVID-19: a meta-analysis","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:53Z","timestamp":1791560993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666634026002709"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101267","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonist exposure in the periconceptional period and adverse obstetric outcomes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101267"}}